Alfredo Budillon
Alfredo Budillon
Istituto Tumori Napoli G. Pascale
Email verificata su
Citata da
Citata da
Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients
G Siravegna, B Mussolin, M Buscarino, G Corti, A Cassingena, ...
Nature medicine 21 (7), 795-801, 2015
Critical role of both p27KIP1and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 (‘Iressa’), an epidermal growth factor receptor tyrosine kinase inhibitor, in …
E Di Gennaro, M Barbarino, F Bruzzese, S De Lorenzo, M Caraglia, ...
Journal of cellular physiology 195 (1), 139-150, 2003
cAMP-dependent protein kinase: role in normal and malignant growth
YS Cho-Chung, S Pepe, T Clair, ADO Budillon, M Nesterova
Critical reviews in oncology/hematology 21 (1-3), 33-61, 1995
Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine
M Donadelli, C Costanzo, S Beghelli, MT Scupoli, M Dandrea, A Bonora, ...
Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1773 (7), 1095-1106, 2007
Emerging anti-cancer molecular mechanisms of aminobisphosphonates
M Caraglia, D Santini, M Marra, B Vincenzi, G Tonini, A Budillon
Endocrine-related cancer 13 (1), 7-26, 2006
Modulation of pancreatic cancer chemoresistance by inhibition of TAK1
D Melisi, Q Xia, G Paradiso, J Ling, T Moccia, C Carbone, A Budillon, ...
Journal of the National Cancer Institute 103 (15), 1190-1204, 2011
Electromagnetic fields at mobile phone frequency induce apoptosis and inactivation of the multi‐chaperone complex in human epidermoid cancer cells
M Caraglia, M Marra, F Mancinelli, G D'ambrosio, R Massa, A Giordano, ...
Journal of cellular physiology 204 (2), 539-548, 2005
The Primary Occurrence of BRAFV600E Is a Rare Clonal Event in Papillary Thyroid Carcinoma
A Guerra, MR Sapio, V Marotta, E Campanile, S Rossi, I Forno, ...
The Journal of Clinical Endocrinology & Metabolism 97 (2), 517-524, 2012
New perspective for an old antidiabetic drug: metformin as anticancer agent
A Leone, E Di Gennaro, F Bruzzese, A Avallone, A Budillon
Advances in Nutrition and Cancer, 355-376, 2014
HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT
F Bruzzese, A Leone, M Rocco, C Carbone, G Piro, M Caraglia, ...
Journal of cellular physiology 226 (9), 2378-2390, 2011
Expression of COX‐2, mPGE‐synthase1, MDR‐1 (P‐gp), and Bcl‐xL: a molecular pathway of H pylori‐related gastric carcinogenesis
G Nardone, A Rocco, D Vaira, S Staibano, A Budillon, F Tatangelo, ...
The Journal of pathology 202 (3), 305-312, 2004
A High Percentage of BRAFV600E Alleles in Papillary Thyroid Carcinoma Predicts a Poorer Outcome
A Guerra, L Fugazzola, V Marotta, M Cirillo, S Rossi, V Cirello, I Forno, ...
The Journal of Clinical Endocrinology & Metabolism 97 (7), 2333-2340, 2012
Frequent overexpression of multiple ErbB receptors by head and neck squamous cell carcinoma contrasts with rare antibody immunity in patients
R Bei, A Budillon, L Masuelli, V Cereda, D Vitolo, E Di Gennaro, ...
The Journal of Pathology: A Journal of the Pathological Society of Great …, 2004
Acetylation of proteins as novel target for antitumor therapy
E Di Gennaro, F Bruzzese, M Caraglia, A Abruzzese, A Budillon
Amino acids 26 (4), 435-441, 2004
The multidrug transporter P-glycoprotein: a mediator of melanoma invasion?
M Colone, A Calcabrini, L Toccacieli, G Bozzuto, A Stringaro, M Gentile, ...
Journal of Investigative Dermatology 128 (4), 957-971, 2008
An antisense oligodeoxynucleotide that depletes RIα subunit of cyclic AMP-dependent protein kinase induces growth inhibition in human cancer cells
H Yokozaki, A Budillon, G Tortora, S Meissner, SL Beaucage, K Miki, ...
Cancer research 53 (4), 868-872, 1993
The role of eukaryotic initiation factor 5A in the control of cell proliferation and apoptosis
M Caraglia, M Marra, G Giuberti, AM D'alessandro, A Budillon, ...
Amino acids 20 (2), 91-104, 2001
New pharmacokinetic and pharmacodynamic tools for interferon-alpha (IFN-α) treatment of human cancer
P Tagliaferri, M Caraglia, A Budillon, M Marra, G Vitale, C Viscomi, ...
Cancer Immunology, Immunotherapy 54 (1), 1-10, 2005
Modulation of molecular mechanisms involved in protein synthesis machinery as a new tool for the control of cell proliferation
M Caraglia, A Budillon, G Vitale, G Lupoli, P Tagliaferri, A Abbruzzese
European journal of biochemistry 267 (13), 3919-3936, 2000
The farnesyl transferase inhibitor R115777 (Zarnestra®) synergistically enhances growth inhibition and apoptosis induced on epidermoid cancer cells by Zoledronic acid (Zometa …
M Caraglia, AM D'Alessandro, M Marra, G Giuberti, G Vitale, C Viscomi, ...
Oncogene 23 (41), 6900-6913, 2004
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20